Femtobiomed (XKRX:327610) FCF Margin % : -731.11% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Femtobiomed's Free Cash Flow for the six months ended in Dec. 2023 was ₩-2,441.6 Mil. Femtobiomed's Revenue for the six months ended in Dec. 2023 was ₩334.0 Mil. Therefore, Femtobiomed's FCF Margin % for the quarter that ended in Dec. 2023 was -731.11%.

As of today, Femtobiomed's current FCF Yield % is -3.46%.

The historical rank and industry rank for Femtobiomed's FCF Margin % or its related term are showing as below:

XKRX:327610' s FCF Margin % Range Over the Past 10 Years
Min: -2388.24 Med: -1210.16 Max: -307.35
Current: -731.11

During the past 6 years, the highest FCF Margin % of Femtobiomed was -307.35%. The lowest was -2388.24%. And the median was -1210.16%.

XKRX:327610's FCF Margin % is ranked worse than
72.64% of 1038 companies
in the Biotechnology industry
Industry Median: -136.31 vs XKRX:327610: -731.11

Femtobiomed FCF Margin % Historical Data

The historical data trend for Femtobiomed's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed FCF Margin % Chart

Femtobiomed Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,347.85

-1,072.47

-1,584.14

-2,388.24

-731.11

Femtobiomed Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Margin %	Get a 7-Day Free Trial			-1,347.85	-1,072.47	-1,584.14	-2,388.24	-731.11

Competitive Comparison of Femtobiomed's FCF Margin %

For the Biotechnology subindustry, Femtobiomed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Femtobiomed's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Femtobiomed's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Femtobiomed's FCF Margin % falls into.

Femtobiomed FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Femtobiomed's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2441.567	/	333.954
	=	-731.11 %

Femtobiomed's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2441.567	/	333.954
	=	-731.11 %

Femtobiomed FCF Margin % Related Terms

Thank you for viewing the detailed overview of Femtobiomed's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Femtobiomed (XKRX:327610) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

https://www.femtobiomed.com

Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed (XKRX:327610) Headlines

No Headlines